# Voximetry

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/voximetry

- Industry: Healthcare Specialists
- Headquarters: Madison, US
- Website: www.voximetry.com/
- Total disclosed funding: $4.6M
- Latest round: Seed (Jun 23, 2023)
- Investors on record: 1

## About

Based in Wisconsin, US, and founded in 2016 by co-founders Paul Wickre, Bryan Bednarz, PhD, and Joseph Grudzinski, PhD, Voximetry, Inc. operates as a provider of dosimetry-guided radiopharmaceutical therapy (DG-RPT) solutions to help doctors customize cancer treatments for prostate and other cancer patients. In September 2023, Voximetry, Inc. raised USD 5 million in pre-series A funding led by the company's management, with participation from WARF Ventures. As of 2024, the company is led by its CEO, Sue Wallace, PhD.

The company offers Torc software for dosimetry-guided radiopharmaceutical therapy (DG-RPT) that includes absorbed dose calculation, treatment planning, adaptive planning, and dose distribution evaluation. Additionally, Torc simplifies personalized RPT assessment with GPU acceleration, providing accurate dosing, DICOM image import, automatic alignment, activity integration, Monte Carlo radiation transport calculations, and detailed dose evaluation reports. 

The company plans to use its proceeds from September 2023 funding to develop the torch dose assessment as an imaging biomarker for personalized treatments.

## Funding rounds

- Seed, Jun 23, 2023, $4.6M — WARF Ventures

## Investors

- WARF Ventures (https://capitalatlas.ai/funds/warf-ventures) — Seed